CYLIOS Trademark

Trademark Overview


On Wednesday, June 28, 2017, a trademark application was filed for CYLIOS with the United States Patent and Trademark Office. The USPTO has given the CYLIOS trademark a serial number of 79221767. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, February 25, 2024. This trademark is owned by NOVARTIS AG. The CYLIOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, immune system, cardiovascular system, metabolic system, endocrine system, respiratory system, musculoskeletal system and genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular diseases and disorders, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infectious, antiviral and antibiotic preparations
cylios

General Information


Serial Number79221767
Word MarkCYLIOS
Filing DateWednesday, June 28, 2017
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, February 25, 2024
Registration Number5527027
Registration DateTuesday, July 31, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2018

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, immune system, cardiovascular system, metabolic system, endocrine system, respiratory system, musculoskeletal system and genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular diseases and disorders, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infectious, antiviral and antibiotic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, August 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, November 28, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, January 19, 2018REFUSAL PROCESSED BY IB
Thursday, November 23, 2017SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, December 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 7, 2017ASSIGNED TO EXAMINER
Monday, December 11, 2017NON-FINAL ACTION WRITTEN
Tuesday, December 12, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, December 12, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 21, 2017REFUSAL PROCESSED BY MPU
Thursday, December 21, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 16, 2018FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 24, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 24, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 15, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 15, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, October 31, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, November 16, 2018FINAL DISPOSITION PROCESSED
Tuesday, October 8, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, October 8, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, July 4, 2022NOTIFICATION PROCESSED BY IB
Friday, December 7, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, August 21, 2021DEATH OF INTERNATIONAL REGISTRATION
Saturday, August 21, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, December 12, 2021NOTIFICATION PROCESSED BY IB